A Study in Patients With Rheumatoid Arthritis
NCT00966875
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
448
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL:
LY2439821
DRUG:
Placebo
Sponsor
Eli Lilly and Company